CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-05 | Barbo William D Corporate Executive VP & CCO | Sale | −8,961 | $164.09 | $1.5M | 21,240 |
| 2020-03-05 | Barbo William D Corporate Executive VP & CCO | Sale | −5,005 | $164.81 | $825K | 16,235 |
| 2020-03-05 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options (Right to Buy) | −3,015 | 0 | ||
| 2020-03-05 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options (Right to Buy) | −3,492 | 3,493 | ||
| 2020-03-05 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options (Right to Buy) | −3,205 | 6,409 | ||
| 2020-03-05 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options (Right to Buy) | −2,755 | 8,266 | ||
| 2020-03-02 | Andrews Nancy C Director | Grant or award | +124 | 124 | ||
| 2020-03-02 | Andrews Nancy C Director | Grant or award · Stock Options (Right to Buy) | +573 | $164.30 | $94K | 573 |
| 2020-02-27 | CHUBB STEPHEN D Director | Option exercise | +4,030 | $43.39 | $175K | 38,865 |
| 2020-02-27 | CHUBB STEPHEN D Director | Option exercise | +3,140 | $70.29 | $221K | 42,005 |
| 2020-02-27 | CHUBB STEPHEN D Director | Sale | −2,464 | $160.89 | $396K | 39,541 |
| 2020-02-27 | CHUBB STEPHEN D Director | Option exercise · Stock Options (Right to Buy) | −4,030 | 0 | ||
| 2020-02-27 | CHUBB STEPHEN D Director | Option exercise · Stock Options (Right to Buy) | −3,140 | 0 | ||
| 2020-02-26 | Smith David Ross Corporate Executive VP & CFO | Option exercise | +4,188 | $73.70 | $309K | 24,663 |
| 2020-02-26 | Smith David Ross Corporate Executive VP & CFO | Sale | −868 | $160.45 | $139K | 23,795 |
| 2020-02-26 | Smith David Ross Corporate Executive VP & CFO | Sale | −898 | $161.58 | $145K | 22,897 |
| 2020-02-26 | Smith David Ross Corporate Executive VP & CFO | Sale | −1,027 | $162.27 | $167K | 21,870 |
| 2020-02-26 | Smith David Ross Corporate Executive VP & CFO | Sale | −657 | $163.38 | $107K | 21,213 |
| 2020-02-26 | Smith David Ross Corporate Executive VP & CFO | Sale | −738 | $164.19 | $121K | 20,475 |
| 2020-02-26 | Smith David Ross Corporate Executive VP & CFO | Option exercise · Stock Options (Right to Buy) | −4,188 | 0 |
Page 56 of 60 · 1,185 trades